

6 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| BLUESTEM VIC III QPFiled to raise in 2026, with no closing reported yet. | 2026 | $6.7M | $0 | 0 |
| BLUESTEM VIC IIIFiled to raise in 2026, with no closing reported yet. | 2026 | $6.7M | $0 | 0 |
| BLUESTEM VIC II | October 2021 | Indefinite | $650,000 | 5 |
| BLUESTEM VIC II QP | October 2021 | Indefinite | $200,000 | 1 |
| Bluestem VIC | August 2019 | $13M | $12M | 60 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
6 partners are named across this firm’s filings, 6 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Drew Doshier | Quiet | None listed | 0 | 0 |
| Jon Kirby | Quiet | None listed | 0 | 0 |
| Nikole Mulder | Quiet | None listed | 0 | 0 |
| Sandy Horst | Quiet | Climate & energy, Medical devices | 2 | 0 |
| Steve Kirby | Quiet | Medical devices, Climate & energy, Enterprise software | 6 | 0 |
| Tyler Stowater | Quiet | None listed | 14 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Classified sectors of Bluestem VIC’s own portfolio companies, based on 20 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Bluestem VIC’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| Arboretum Ventures | 1 | Virtual Incision |
| Versant Affiliates | 1 | Neurolens |
| Versant Venture Capital | 1 | Neurolens |
A shared board seat: a company where filings name a Bluestem VIC partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.